Time to onset and duration of botulinum toxin efficacy in movement disorders.

J Neurol · 2022 · PMC9217780 · PMID 35113259

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Covariance analysis confirmed that the type of condition for which the patient is treated is highly significant in determining duration of BoNT efficacy ( p < 0.001), independently from age, doses, and type of toxin.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.